| | 548-73-2 Basic information More.. |
| Product Name: | DROPERIDOL | | Synonyms: | 1-{1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl}-2-benzimidazolinone;2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-;2-benzimidazolinone,1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyri;2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-;3-dihydro-4-pyridinyl)-;component of Innovar;component of Thalamonal;Dehidrobenzperidol | | CAS: | 548-73-2 | | MF: | C22H22FN3O2 | | MW: | 379.43 | | EINECS: | 208-957-8 | | Mol File: | 548-73-2.mol |  |
Use
Droperidol, 1-1-[3-(p-fluorobenzoyl)propyl]-1,2,[3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone(Inapsine). Centrally acting acetylcholinesteraseinhibitors may increase the risk of antipsychotic-relatedEPS. CNS depressants may produce additive sedativeeffects (benzodiazepines, barbiturates, antipsychotics,ethanol, opiates, and other sedative medications).Droperidol in combination with certain forms of inhalationanesthetics may produce peripheral vasodilatation and hypotension.Metoclopramide may increase the risk of EPSproduced by droperidol.
- Droperidol
-
- US $91.00-55.00 / mg
- 2025-09-10
- CAS:548-73-2
- Min. Order:
- Purity: 98.38%
- Supply Ability: 10g
- Droperidol
-
- US $91.00-55.00 / mg
- 2025-09-10
- CAS:548-73-2
- Min. Order:
- Purity: 98.38%
- Supply Ability: 10g
- Droperidol
-
- US $55.00-91.00 / mg
- 2025-05-02
- CAS:548-73-2
- Min. Order:
- Purity: 98.38%
- Supply Ability: 10g
|
|
548-73-2
Recommend Suppliers |
|